Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes
Atypical Parkinsonian syndromes include multiple systems atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). These conditions show signs of dopamine deficiency, but unlike Parkinson’s disease (PD), they do not respond to dopamine...
Main Authors: | Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2020-06-01
|
Series: | Türk Nöroloji Dergisi |
Subjects: | |
Online Access: | http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-45467&look4= |
Similar Items
-
Challenges and Opportunities in Atypical Parkinsonian Syndromes: Call to Action
by: Roach M, et al.
Published: (2020-01-01) -
Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders
by: Sonja W. Scholz, et al.
Published: (2015-10-01) -
Of Criteria and Men—Diagnosing Atypical Parkinsonism: Towards an Algorithmic Approach
by: Liviu Cozma, et al.
Published: (2021-05-01) -
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
by: Rachel Rohmann, et al.
Published: (2021-06-01) -
The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
by: Monica Diez-Fairen, et al.
Published: (2021-07-01)